Home
Conditions
Neurofibroma

Clinical trial condition

Neurofibroma

Explore clinical trials studying Neurofibroma. Study availability and eligibility vary by location and protocol.

235 public trials 39 recruiting studies

Refine in advanced search Browse all conditions

Neurofibroma trial results

Completed

Trial to Evaluate the Safety of Lovastatin in Individuals With Neurofibromatosis Type I (NF1)

NCT00352599

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +13 more
Locations: Semel Institute for Neuroscience and Human Behavior Los Angeles, California, United States

View Trial Details

Completed

Phase II Study of Imatinib Mesylate in Patients With Life Threatening Malignant Rare Diseases

NCT00154388

Conditions: Adenocarcinoma, Adenoma, Adnexal Diseases, +121 more
Locations: Not specified

View Trial Details

Completed

Neuropsychological Impairment and Quality of Life in Neurofibromatosis Type 1

NCT01851135

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +14 more
Locations: Assistance Publique - Hôpitaux de Paris (Hôpital Henri Mondor) Créteil, France

Centre Hospitalier Universitaire de Nantes Nantes, France

View Trial Details

Completed

Surgery With or Without Radiation Therapy in Treating Patients With Primary Soft Tissue Sarcoma of the Retroperitoneum or Pelvis

NCT00091351

Conditions: Fibrosarcoma, Hemangiosarcoma, Histiocytoma, +23 more
Locations: Arkansas Cancer Research Center at University of Arkansas for Medical Sciences Little Rock, Arkansas, United States

City of Hope Comprehensive Cancer Center Duarte, California, United States

University of Colorado Cancer Center at University of Colorado Health Sciences Center Aurora, Colorado, United States

George Washington University Medical Center Washington D.C., District of Columbia, United States

View all 59 locations

View Trial Details

Completed

Resiliency Training for Patients With Neurofibromatosis Via Videoconferencing With Skype

NCT02298270

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +30 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

View Trial Details

Completed

Cixutumumab and Doxorubicin Hydrochloride in Treating Patients With Unresectable, Locally Advanced, or Metastatic Soft Tissue Sarcoma

NCT00720174

Conditions: Adult Angiosarcoma, Adult Desmoplastic Small Round Cell Tumor, Adult Epithelioid Sarcoma, +64 more
Locations: University of Chicago Comprehensive Cancer Center Chicago, Illinois, United States

Decatur Memorial Hospital Decatur, Illinois, United States

NorthShore University HealthSystem-Evanston Hospital Evanston, Illinois, United States

Ingalls Memorial Hospital Harvey, Illinois, United States

View all 13 locations

View Trial Details

Completed

Phase II Study of Gleevec/Imatinib Mesylate (STI-571, NCS 716051) in Neurofibromatosis (NF1) Patients With Plexiform Neurofibromas

NCT01673009

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Genetic Diseases, Inborn, Heredodegenerative Disorders, Nervous System, +11 more
Locations: Indiana University Indianapolis, Indiana, United States

View Trial Details

Completed

Lapatinib Study for Children and Adults With Neurofibromatosis Type 2 (NF2) and NF2-Related Tumors

NCT00973739

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cranial Nerve Diseases, Cranial Nerve Neoplasms, +28 more
Locations: New York University School of Medicine New York, United States

View Trial Details

Completed

Phase II Trial of Sunitinib (SU011248) in Patients With Recurrent or Inoperable Meningioma

NCT00589784

Conditions: Brain Diseases, Brain Neoplasms, CNS Cancer, +42 more
Locations: Dana Farber Cancer Institute Boston, Massachusetts, United States

Memoral Sloan Kettering Cancer Center Basking Ridge, New Jersey, United States

Memorial Sloan-Kettering Cancer Center at Commack Commack, New York, United States

Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Safety Study of Recombinant Vaccinia Virus to Treat Refractory Solid Tumors in Pediatric Patients

NCT01169584

Conditions: Congenital, Hereditary, and Neonatal Diseases and Abnormalities, DNA Virus Infections, Ewing's Sarcoma, +54 more
Locations: Cincinnati Children's Hospital Medical Center Cincinnati, Ohio, United States

Texas Children's Hospital Houston, Texas, United States

View Trial Details

Neurofibroma

Neurofibroma trial results

Related conditions